0001104659-20-005263.txt : 20200117
0001104659-20-005263.hdr.sgml : 20200117
20200117214843
ACCESSION NUMBER: 0001104659-20-005263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200116
FILED AS OF DATE: 20200117
DATE AS OF CHANGE: 20200117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norry Elliot
CENTRAL INDEX KEY: 0001798117
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37368
FILM NUMBER: 20534922
MAIL ADDRESS:
STREET 1: 351 ROUSE BOULEVARD
CITY: PHILADELPHIA
STATE: PA
ZIP: 19112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC
CENTRAL INDEX KEY: 0001621227
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 JUBILEE AVENUE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RX
BUSINESS PHONE: 44 1235 430000
MAIL ADDRESS:
STREET 1: 60 JUBILEE AVENUE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RX
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptimmune Ltd
DATE OF NAME CHANGE: 20141001
4
1
a4.xml
4
X0306
4
2020-01-16
0
0001621227
Adaptimmune Therapeutics PLC
ADAP
0001798117
Norry Elliot
C/O ADAPTIMMUNE THERAPEUTICS PLC,
60 JUBILEE AVENUE, MILTON PARK
ABINGDON
X0
OX14 4RX
UNITED KINGDOM
0
1
0
0
Chief Medical Officer
Option to purchase Ordinary Shares
0.74
2020-01-16
4
A
0
201600
0
A
2030-01-16
Ordinary Shares
201600
201600
D
Option to purchase Ordinary Shares
0.0013
2020-01-16
4
A
0
135600
0
A
Ordinary Shares
135600
135600
D
The exercise price was converted from GBP0.57 based on an exchange rate of U.S$1.302659 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Exercisable as to 50,400 Ordinary Shares on January 16, 2021 and will be exercisable as to the remainder in monthly installments of 4,200 Ordinary Shares on the sixteenth of each month from February 16, 2021 through January 16, 2024.
The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$1. 302659 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Exercisable as to 33,900 Ordinary Shares on January 16, 2021 and will be exercisable as to the remainder in annual installments of 33,900 Ordinary Shares on the sixteenth of each January from January 16, 2022 through January 16, 2024.
The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable.
/s/ Elliot Norry
2020-01-17